Facebook page "JSP Pharma - JP สุภาพโอสถ70ปี" impersonates "JSP Pharmaceutical Manufacturing (Thailand) Plc." : Unlicensed securities and derivatives business (Disclosure Date : 05/03/2025)

decelerating rate due to slowdown in external sector and manufacturing production at home. Meanwhile, private consumption which continued to expand was derived mainly from increased expenditures on automobiles

action may be pursued, which may lead to imprisonment and fines. If such activities contravene other laws, the SEC will collaborate with relevant authorities to take further action.  Mrs. Waratchya

imprisonment and fines. If such activities contravene other laws, the SEC will collaborate with relevant authorities to take further action.    In case of finding solicitation or being solicited for investment

capital market. The fraudulent activities include forging licenses and falsely claiming certification of the SEC and official authorities. There were deceptive uses of names and images of market

volatile during this quarter. However, Thailand’s financial stability was satisfactory due to a high current account surplus and rising demand for imported raw materials used in export-oriented manufacturing

rendering a verdict. In this regard, the SEC will monitor the progress of the ongoing legal proceedings and fully cooperate with relevant authorities in subsequent processes after the filing of the criminal

judicial discretion of the court in rendering a verdict. In this regard, the SEC will monitor the progress of the ongoing legal proceedings and fully cooperate with relevant authorities in subsequent

approved to be a locally incorporated institution (LII) under the name KASIKORNBANK (CHINA) COMPANY LIMITED, we now plan to seek approval from the Chinese authorities for operating additional businesses to

ก () (LPN https://market.sec.or.th/PUBLIC/MRAP/MRAPFile.aspx?FILESEQUENCE=0&FUNDNAME=TISESG&FUNDCOMPRUNCODE=MF... 22012327.pdf ., manufacturing, property , and logistics. EBITDA expands in low-single